The Patent Finder
US

Therapeutic Use of ANTI-CS1 Antibodies

US 10,442,859 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Aug 19, 2025 · Medium confidence

Filed Sep 22, 2015 as application 14/860,906 · Granted Oct 15, 2019
Base term plus 469 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Aug 19, 2025
2004 2026
Clock starts
May 7, 2004
Term ended
Aug 19, 2025
Granted
Oct 15, 2019
base term patent term adjustment after the term ends fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
469
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,709,610, to Aug 19, 2025. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 469 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 7, 2004, when application 10/842,011, the earliest non-provisional in its chain, was filed (this one was filed Sep 22, 2015); a parent in its chain could not be resolved (the next row)May 7, 2024High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+469 days, USPTO patent term adjustment recordAug 19, 2025High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,709,610)resolves to Aug 19, 2025, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderAug 19, 2025Medium confidence

Partial family

Application 10/842,011Abandoned
not computed
not computed
US 7,709,610In force
no later than Aug 2029
no later than Aug 2029
US 8,008,450Term ended
no later than May 2024
no later than May 2024
US 8,445,646Term ended
no later than May 2024
no later than May 2024
US 9,175,081Term ended
no later than May 2024
no later than May 2024
US 10,442,859this patent
Aug 2025
Aug 2025
Partial: 2 of the 6 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 13, 2015
Reel 37031, frame 929
Williams, Marna; Tso, J. Yun; Landolfi, Nicholas F.Protein Design Labs, Inc.Assignment of Assignor's Interest
Nov 13, 2015
Reel 37033, frame 603
PDL Biopharma, Inc.Facet Biotech CorporationAssignment of Assignor's Interest
Nov 13, 2015
Reel 37033, frame 478
Liu, GaoPDL BiopharmaAssignment of Assignor's Interest
Nov 13, 2015
Reel 37034, frame 115
Abbott Biotherapeutics Corp.AbbVie Biotherapeutics Inc.Change of Name
Nov 13, 2015
Reel 37111, frame 396
Protein Design Labs, Inc.PDL Biopharma, Inc.Change of Name
Nov 13, 2015
Reel 37111, frame 410
Facet Biotech CorporationAbbott Biotherapeutics Corp.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited